2m 2m 2m 2m 2m 2m 2m
CG ONCOLOGY (CGON)
NASDAQ
$72.30+$1.11 (+1.55%)
Price as of Aug 03, 2026 4:34 AM EDT- $6.3BMarket Cap
- 170.58%1-Year Change
- BiotechnologyIndustry
CG ONCOLOGY (CGON)
$72.30+$1.11 (+1.55%)
CGON | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $71.19 | ||
Change | -$1.84 (-2.52%) | ||
Open | $72.94 | ||
High | $72.94 | ||
Low | $69.60 | ||
Previous Close | $73.03 | ||
Volume | 560,824 | ||
30-Day Average Volume | 942,019 | ||
1-Week Change | 2.70% | ||
1-Month Change | 0.20% | ||
1-Year Change | 170.58% | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 88.2M | ||
Total Assets | $1.1B | ||
Market Cap | $6.3B | ||
Enterprise Value | $6.2B | ||
Period: QTR TTM FY | |||
Revenue | $1.1M | ||
Net Income | -$60.2M | ||
Free Cash Flow | -$57.2M | ||
EBIT | -$60.2M | ||
EBITDA | -$59.4M | ||
Net Working Capital | $1.1B | ||
EPS | -$0.71 | ||
Enterprise Value/EBITDA | -105 | ||
Enterprise Value/Revenue | 5,845 | ||
P/B | 6 | ||
P/E | -100 | ||
PEG | 3 | ||
Price/Free Cash Flow | -110 | ||
Price/Operating Cash Flow | -110 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue